|
|
| | obelmycin D Basic information |
| Product Name: | obelmycin D | | Synonyms: | obelmycin D;(3''S,3'''''S)-1,3'',3'''''-Trihydroxycytorhodin A;5,12-Naphthacenedione, 8-ethyl-7,8,9,10-tetrahydro-1,4,6,8,11-pentahydroxy-7,10-bis[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2S,5S,6S)-tetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy]-, (7R,8R,10S)- (9CI) | | CAS: | 107807-17-0 | | MF: | C60H88N2O23 | | MW: | 1205.36 | | EINECS: | | | Product Categories: | | | Mol File: | 107807-17-0.mol |  |
| | obelmycin D Chemical Properties |
| density | 1.44±0.1 g/cm3(Predicted) | | pka | 6.92±0.70(Predicted) |
| | obelmycin D Usage And Synthesis |
| Description | Obelmycin D is an anthracycline antibiotic, a beta-isorhodomycinone glycoside from Streptomyces violaceus. |
| | obelmycin D Preparation Products And Raw materials |
|